Boardroom Alpha
Boardroom Alpha
PARK · Current Report (Form 8-K) · Filed June 2, 2026

Park Dental Partners Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 2, 2026
Period
May 29, 2026
Ticker
PARK
Accession
0001104659-26-069461
Boardroom Alpha · Filing insights

Christopher C. Smith elected Class II director; Deloitte & Touche LLP ratified as auditor for 2026.

About Park Dental Partners Inc
Market cap
$90M
Board grade
A
Sector
Healthcare
Last annual meeting: May 29, 2026 · View full Park Dental Partners Inc profile →

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 29, 2026

 

Park Dental Partners, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Minnesota  001-42967  93-2020683
(State or Other Jurisdiction of  (Commission  (IRS Employer
Incorporation)  File Number)  Identification No.)

 

2200 County Road C West, Suite 2210

Roseville, Minnesota 55113

(Address of Principal Executive Offices) (Zip Code) 

 

(651) 633-0500

(Registrant's Telephone Number, Including Area Code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading
Symbol
(s)
Name of each exchange
on which registered
Common Stock, par value $0.0001 per share PARK The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

 

* * *

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On May 29, 2026, Park Dental Partners, Inc. (the “Company”) held its 2026 Annual Meeting of Shareholders (the “Annual Meeting”) for the purposes of (i) electing the Class II director named in the definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April 10, 2026 (the “Proxy Statement”); and (ii) ratifying the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

 

As of the record date of March 30, 2026, there were 6,608,919 shares of the Company’s common stock, par value $0.0001 per share, entitled to vote at the Annual Meeting, including restricted shares entitled to vote prior to vesting. A total of 5,279,595 shares were represented in person or by proxy at the Annual Meeting, constituting a quorum. The final results of the shareholder vote are set forth below.

 

Proposal 1: Election of Director

 

The Company’s shareholders elected Christopher C. Smith as a Class II director to serve until the Company’s 2029 annual meeting of shareholders and until his successor is duly elected and qualified. The director was elected by the votes indicated.

 

Nominee  For   Withheld   Broker Non-Votes 
Christopher C. Smith   4,214,835    586,587    478,173 

 

Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm

 

The Company’s shareholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The appointment was ratified by the votes indicated.

 

For  Against   Abstain   Broker Non-Votes 
5,145,444   1,047    133,104         0 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No. Description
   
104 Cover Page Interactive Data File (formatted as Inline XBRL).

 

* * *

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PARK DENTAL PARTNERS, INC.
   
Date: June 2, 2026 By: /s/ Peter G. Swenson
  Name: Peter G. Swenson
  Title: Chief Executive Officer and Chair

 

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Park Dental Partners Inc (PARK)

Reference

Frequently asked questions

When did Park Dental Partners Inc file this 8-K?
Park Dental Partners Inc (PARK) filed this Current Report (Form 8-K) with the SEC on June 2, 2026. The accession number assigned by EDGAR is 0001104659-26-069461.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Christopher C. Smith elected Class II director; Deloitte & Touche LLP ratified as auditor for 2026. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Park Dental Partners Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Park Dental Partners Inc has filed under CIK 2069604, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer